|
1
|
Biddlestone-Thorpe L, Sajjad M, Rosenberg
E, Beckta JM, Valerie NC, Tokarz M, Adams BR, Wagner AF, Khalil A,
Gilfor D, et al: ATM kinase inhibition preferentially sensitizes
p53-mutant glioma to ionizing radiation. Clin Cancer Res.
19:3189–3200. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang SC, Wu CC, Wei YY, Hong JH and Chiang
CS: Inactivation of ataxia telangiectasia mutated gene can increase
intracellular reactive oxygen species levels and alter
radiation-induced cell death pathways in human glioma cells. Int J
Radiat Biol. 87:432–442. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lomonaco SL, Finniss S, Xiang C,
Decarvalho A, Umansky F, Kalkanis SN, Mikkelsen T and Brodie C: The
induction of autophagy by gamma-radiation contributes to the
radioresistance of glioma stem cells. Int J Cancer. 125:717–722.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hambardzumyan D, Becher OJ, Rosenblum MK,
Pandolfi PP, Manova-Todorova K and Holland EC: PI3K pathway
regulates survival of cancer stem cells residing in the
perivascular niche following radiation in medulloblastoma in vivo.
Genes Dev. 22:436–448. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou W, Sun M, Li GH, Wu YZ, Wang Y, Jin
F, Zhang YY, Yang L and Wang DL: Activation of the phosphorylation
of ATM contributes to radioresistance of glioma stem cells. Oncol
Rep. 30:1793–1801. 2013.PubMed/NCBI
|
|
6
|
Jackson SP: Sensing and repairing DNA
double-strand breaks. Carcinogenesis. 23:687–696. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Knizhnik AV, Roos WP, Nikolova T, Quiros
S, Tomaszowski KH, Christmann M and Kaina B: Survival and death
strategies in glioma cells: Autophagy, senescence and apoptosis
triggered by a single type of temozolomide-induced DNA damage. PLoS
One. 8:e556652013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nadkarni A, Shrivastav M, Mladek AC,
Schwingler PM, Grogan PT, Chen J and Sarkaria JN: ATM inhibitor
KU-55933 increases the TMZ responsiveness of only inherently TMZ
sensitive GBM cells. J Neurooncol. 110:349–357. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gil del Alcazar CR, Hardebeck MC,
Mukherjee B, Tomimatsu N, Gao X, Yan J, Xie XJ, Bachoo R, Li L,
Habib AA, et al: Inhibition of DNA double-strand break repair by
the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for
radiosensitization of glioblastoma. Clin Cancer Res. 20:1235–1248.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Golding SE, Rosenberg E, Adams BR,
Wignarajah S, Beckta JM, O'Connor MJ and Valerie K: Dynamic
inhibition of ATM kinase provides a strategy for glioblastoma
multiforme radiosensitization and growth control. Cell Cycle.
11:1167–1173. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Raso A, Vecchio D, Cappelli E, Ropolo M,
Poggi A, Nozza P, Biassoni R, Mascelli S, Capra V, Kalfas F, et al:
Characterization of glioma stem cells through multiple stem cell
markers and their specific sensitization to double-strand
break-inducing agents by pharmacological inhibition of ataxia
telangiectasia mutated protein. Brain Pathol. 22:677–688. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Finnegan EJ and Matzke MA: The small RNA
world. J Cell Sci. 116:4689–4693. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chuah TL, Walker DG, Wei M, Scott S and
Lavin MF: Approaches to sensitizing glioblastoma to radiotherapy:
Use of lentiviral vectors. Int J Oncol. 40:1963–1969.
2012.PubMed/NCBI
|
|
14
|
Guha C, Guha U, Tribius S, Alfieri A,
Casper D, Chakravarty P, Mellado W, Pandita TK and Vikram B:
Antisense ATM gene therapy: A strategy to increase the
radiosensitivity of human tumors. Gene Ther. 7:852–858. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vecchio D, Daga A, Carra E, Marubbi D,
Baio G, Neumaier CE, Vagge S, Corvò R, Pia Brisigotti M, Ravetti J
Louis, et al: Predictability, efficacy and safety of
radiosensitization of glioblastoma-initiating cells by the ATM
inhibitor KU-60019. Int J Cancer. 135:479–491. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells - perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Golestaneh AF, Atashi A, Langroudi L,
Shafiee A, Ghaemi N and Soleimani M: miRNAs expressed differently
in cancer stem cells and cancer cells of human gastric cancer cell
line MKN-45. Cell Biochem Funct. 30:411–418. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Moschos SJ, Dodd NR, Jukic DM, Fayewicz
SL, Wang X and Becker D: Suppressing the high-level expression and
function of ATM in advanced-stage melanomas does not sensitize the
cells to ionizing radiation. Cancer Biol Ther. 8:1815–1825. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Squatrito M, Brennan CW, Helmy K, Huse JT,
Petrini JH and Holland EC: Loss of ATM/Chk2/p53 pathway components
accelerates tumor development and contributes to radiation
resistance in gliomas. Cancer Cell. 18:619–629. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Burdak-Rothkamm S and Prise KM: New
molecular targets in radiotherapy: DNA damage signalling and repair
in targeted and non-targeted cells. Eur J Pharmacol. 625:151–155.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang XD, Qin ZH and Wang J: The role of
p53 in cell metabolism. Acta Pharmacol Sin. 31:1208–1212. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Poosarla C, Ramesh M, Ramesh K, Gudiseva
S, Bala S and Sundar M: Proliferating cell nuclear antigen in
premalignancy and oral squamous cell carcinoma. J Clin Diagn Res.
9:ZC39–ZC41. 2015.PubMed/NCBI
|
|
23
|
Yang M, Zhai X, Xia B, Wang Y and Lou G:
Long noncoding RNA CCHE1 promotes cervical cancer cell
proliferation via upregulating PCNA. Tumour Biol. 36:7615–7622.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tamm I, Wang Y, Sausville E, Scudiero DA,
Vigna N, Oltersdorf T and Reed JC: IAP-family protein survivin
inhibits caspase activity and apoptosis induced by Fas (CD95), Bax,
caspases, and anticancer drugs. Cancer Res. 58:5315–5320.
1998.PubMed/NCBI
|
|
25
|
Ma X, Yang L, Xiao L, Tang M, Liu L, Li Z,
Deng M, Sun L and Cao Y: Down-regulation of EBV-LMP1
radio-sensitizes nasal pharyngeal carcinoma cells via NF-κB
regulated ATM expression. PLoS One. 6:e246472011. View Article : Google Scholar : PubMed/NCBI
|
